b'SIU ACADEMY: BRINGING EDUCATION ONLINEBENCH-TO-BEDSIDE(B2B) MEETINGSSIU Bench-to-Bedside Uro-Oncology:GU Cancers Triad Virtual MeetingScientific Programme Committee: Peter C. Black (Canada), Ashish Kamat (United State) and Stacy Loeb (United States), Simon Tanguay (Canada), Mlanie Aub-Peterkin (Canada) Presenting Sponsor: Bristol Myers SquibbContributing Sponsors: Exact Imaging, F. Hoffmann-La Roche Ltd., Merck & Co., Merck KGaA, Darmstadt, GermanyPfizer Alliance, Seagen CanadaWith the support of: World Bladder Cancer Patient Coalition (WBCPC)The B2B Uro-Oncology: GU Cancers Triad Meeting was organized by the SIU and held online on May 21 and 22, 2021. This event brought together more than 3,000 attendees from over 90 countries during the two-day programme. Following the event,all content was made available on demand and garnered more than 6,000 views. The SIU Uro-Oncology: GU Cancers Triad Meeting provided an engaging way to review current clinical research advancements and their applications in uro-oncology. The event was attended by leading experts in the field and gave members the opportunity to network and acquire valuable insights during the Q&A and panel sessions.The session on bladder and kidney cancer took place on the morning of May 21 and was chaired by Peter C. Black (Canada), Ashish Kamat (United States), and Simon Tanguay (Canada). The session on prostate cancer was hosted on May 22 and was chaired by Peter C. Black (Canada) and Stacy Loeb (United States).The sessions focused on providing updates on the evolving trends in the early detection of disease, recent results of clinical trials, new therapies, biomarkers, and new technologies and strategies for the treatment of urological cancers. The event was accredited by the European Accreditation Council for Continuing Medical Education (EACCME). Registrants who attended the live broadcasts on May 21 and 22 were eligible to claim up to 6 European CME credits (ECMEC).20 A N N U A L R E P O R T 2 0 2 1'